We can't find the internet
Attempting to reconnect
Retour aux projets
40143.1 IP-LS
40143.1 IP-LS
Résumé
Development of a novel cancer therapy targeting protein modifications in the tumor microenvironment
Textes supplémentaires
Abstract
We are developing a monoclonal antibody-based therapy against a novel target that is upregulated in many solid tumors. With this project, we will generate the proof-of-concept that the therapy will work in preclinical in vivo tumor models.
Participants
Michael Hottiger
Kontaktperson
michael.hottiger@dmmd.uzh.ch
Universität Zürich Michael Hottiger Winterthurerstrasse 190 8057 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2019-12-31
- Date de fin
- 2021-06-30
- Coûts totaux approuvés
- CHF 769327.55
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- B007 Medicine (human and vertebrates) 100.0%